NEW Prelims Cracker 2027 ⚡️ Starts July 1st 📞 Call Now: 9211591415 ★                      ★ NEW GS Foundation 2027 ⚡️ Just Started ⬇️ Download Brochure 📞 Call Now: 9211591415 ★                      ★ PMF IAS Impact 🎯 53 Direct Hits in Prelims 2025 and 🎯 46 Direct Hits in Prelims 2026 ★

National IPR Policy, Intellectual Property Rights Issues

National IPR Policy, 2016

  • The Policy aims to push IPRs as a marketable financial asset, promote innovation & entrepreneurship, while protecting public interest.
  • The plan will be reviewed every five years in consultation with stakeholders.
  • To have strong & effective IPR laws, steps would be taken — including review of existing IP laws — to update & improve them or to remove anomalies & inconsistencies.
  • The policy is entirely compliant with the WTO’s agreement on TRIPS.
  • Department of industrial policy & promotion (DIPP) is the nodal agency for all IPR issues.
  • The policy retains the provisions on Compulsory Licensing (CL) as well as preventing ever-greening of drug patents (Section 3(d) of India’s Patents Act).
  • Under Indian Patents Act, a CL can be issued for a drug if the medicine is deemed unaffordable, among other conditions, & the government grants permission to qualified generic drug makers to manufacture it.

Objectives under the policy are

Intellectual Property Rights Issues: The Five Major Challenges Faced

  • There are many IPR issues that one faces while getting IP rights in India. The issues are as follows:

Patent Evergreening Prevention

  • One of the most important intellectual property rights issues challenges is the prevention of the evergreening of the patents for multinational companies.
  • Evergreening is strategy for extending the term of granted patent which is about to expire without increasing therapeutic efficacy in order to retain royalties.
  • As we know, the companies cannot evergreen their patents simply by making minor changes.
  • So, section 3(d) in the Indian Patent Act (IPA) possess as one of the biggest issues with regards to IPR.
  • This act bars the grant of patents to new forms of substances.
  • This has discouraged investments from western countries.

Subsidies & IPR Issues

  • A major form of subsidies includes food subsidy, fertilizer subsidy, education subsidy, etc.
  • For the complete implementation of TRIPS agreements, one needs to reduce or eliminate these subsidies.
  • Thus, GOI needs to create a balance between providing subsidies & providing IP rights in India.

The Product Patents Process

  • A product patent protects a product.
  • It offers high protection to the original inventor to reduce the competition for the same product.
  • Whereas a process patent protects the process through which one manufactures the product & not the product.
  • It reduces the element of monopoly in the market.
  • As India is a part of the TRIPS agreement, the agreement requires all its members to shift their patent regime from process to product patent.
  • This remains a challenge for India, as process patent would be more helpful to a country like India.
  • This is since India is a developing country & ordinary people are struggling with basic necessities like food.

Protecting traditional knowledge

  • Traditional knowledge, especially in the field of medicine, is like a gold mine.
  • GOI is bound to protect traditional knowledge by not allowing MNC’s to get patents on traditional culture.
  • Above all, the government has created a Traditional Knowledge Digital Library (TKDL) to prevent the patenting of traditional knowledge.
  • So, this is one of the intellectual property rights issues in India.

Compulsory Licensing & Drug Price Control Order

  • One of the most important intellectual property rights issues that the government needs to address is the use of compulsory licensing.
  • Compulsory licenses are authorizations given to a third-party by the Government to make, use or sell a particular patented product without the need of the permission of the patent owner.
  • The provisions regarding compulsory licenses are given in the Indian Patents Act, 1970 & in the TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement.
  • It is a relaxation available to the developing countries under the TRIPS agreement, something which organizations misuse sometimes.
  • Moreover, under section 84 of the IPA, a company can acquire a compulsory license for “private commercial use” under certain circumstances.
  • With the Drug Price Control Order, the company needs to justify the price of the drug with regards to investments.
  • If someone plays foul, then the government has the right to intervene.
  • Multinationals are asking the government to revoke this provision.
  • However, the government is not ceding the demands to protect the interest of the masses.

Some other issues

  • Trademark Violations: India has very high level of trademark counterfeiting against which the authorities in India do not take proper actions.
  • Enforcement of IPR regulations is quite weak in the country because of two important reasons
  • India is key exporter of counterfeit fake products such as foodstuffs, textiles, shoes, electronics etc
  • Judicial delays in IPR disputes
  • India maintains high custom duties on IP intensive products as advocated by western countries impacting the investment (US puts India into priority watch list i.e., special 301 report).

Leave a Reply

Your email address will not be published. Required fields are marked *